Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Azathioprine × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

pembrolizumab 853 Carboplatin 800 Paclitaxel 784 Gemcitabine 657 Cisplatin 634 Docetaxel 591 Bevacizumab 515 Pemetrexed 412 Nivolumab 403 Cyclophosphamide 403 Capecitabine 387 Fluorouracil 335 Dexamethasone 330 Rituximab 320 Oxaliplatin 286 Injections 284 atezolizumab 253 Trastuzumab 247 Cetuximab 233 Leucovorin 232 Irinotecan 218 Prednisone 215 130-nm albumin-bound paclitaxel 215 Doxorubicin 210 Ipilimumab 188 Lenalidomide 186 Fulvestrant 181 fludarabine 180 durvalumab 172 venetoclax 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡